During the past decade, The Chinese University of Hong Kong, Prince of Wale Hospital conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.9% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 1 clinical trials were completed. i.e. 3.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Chinese University of Hong Kong, Prince of Wale Hospital" #1 sponsor was "Chinese University of Hong Kong" with 29 trials, followed by "Daiichi Sankyo, Inc." with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Amryt Research Limited" with 1 trials sponsored and "Arbutus Biopharma Corporation" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Chinese University of Hong Kong, Prince of Wale Hospital" #1 collaborator was "IBM China/Hong Kong Limited" with 2 trials as a collaborator, "Queen Elizabeth Hospital, Hong Kong" with 2 trials as a collaborator, "United Christian Hospital" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Chinese University of Hong Kong" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "The Chinese University of Hong Kong, Prince of Wale Hospital" are "Liver Fibrosis" (5 trials), "Prostate Cancer" (5 trials), "Breast Cancer" (2 trials), "Colorectal Neoplasms" (2 trials) and "Postoperative Ileus" (2 trials). Many other conditions were trialed in "The Chinese University of Hong Kong, Prince of Wale Hospital" in a lesser frequency.

Most popular intervention types in "The Chinese University of Hong Kong, Prince of Wale Hospital" are "Drug" (9 trials), "Procedure" (9 trials), "Other" (6 trials), "Diagnostic Test" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine" (2 trials), "Conventional care (control)" (2 trials), "Dietitian led life style modification intervention" (2 trials), "Electroacupuncture" (2 trials) and "Magrolimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Chinese University of Hong Kong, Prince of Wale Hospital" are 32 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "The Chinese University of Hong Kong, Prince of Wale Hospital". 3 are not yet recruiting, 16 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in The Chinese University of Hong Kong, Prince of Wale Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Chinese University of Hong Kong, Prince of Wale Hospital, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".